chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Body temperature; chills; body aches; This is a spontaneous report received from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: er2013) via an unspecified route of administration in the left arm on an unknown date in Mar2021 at 12:00 (at the age of 52-years-old), as a single dose for COVID-19 immunisation. The patient's medical history was reported as COVID-19 prior to vaccination. The patient did not have a history of allergies to medications, food or other products. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in an unspecified anatomical site on an unspecified date (at the age of 52-years-old), as a single dose for COVID-19 immunisation.  The patient had not received other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient had not received any other medications within 2 weeks of vaccination. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On an unknown date in Mar2021 at 22:00, the patient experienced 99.9 temperature with chills and body aches, similar to when she had Covid-19 in Dec2020. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive treatment for the reported events. On an unspecified date, the patient underwent body temperature recording and the result was temperature 99.9(unspecified units). The clinical outcomes for the events 99.9 temperature with chills and body aches was recovered in 2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Joint swelling and pain, pain and swelling in lymph nodes behind knees, in groin, and armpits.  Muscle pain, fatigue, inflammation in hands and feet. Lasting three weeks now without improvement
vaccination event. Patient was waiting his 15 minutes after receiving the vaccine; he "passed out". The local fire department responded and attended to him. He was not transferred to care
Vaccine had expired on 02-Jul-2022 and it was refrigerated on 07-Jul-2022; Vaccine had expired on 02-Jul-2022 and it was administered on 07-Jul-2022.; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine had expired on 02-Jul-2022 and it was administered on 07-Jul-2022.) and PRODUCT STORAGE ERROR (Vaccine had expired on 02-Jul-2022 and it was refrigerated on 07-Jul-2022) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027l21a) for COVID-19 prophylaxis.     No Medical History information was reported.    On 07-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine had expired on 02-Jul-2022 and it was administered on 07-Jul-2022.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine had expired on 02-Jul-2022 and it was refrigerated on 07-Jul-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine had expired on 02-Jul-2022 and it was administered on 07-Jul-2022.) and PRODUCT STORAGE ERROR (Vaccine had expired on 02-Jul-2022 and it was refrigerated on 07-Jul-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication information was not provided by the reporter.  On 07-Jul-2022, the vial was initially stored in the refrigerator. Patient received second booster shot.  The vial did not undergo any temperature excursions.  Treatment information was not provided by the reporter.   This case was linked to MOD-2022-606413 (Patient Link).
Blisters on lower arms and hands. Hydrocortisone, Rash scabbed over and healed in one week.
patient reported never been vaccinated, requesting moderna, was actually a  3rd dose (0.5ml) .
Yellow Fever (YF-Vax) was given incorrect route of administration. It was given as IM instead of SubQ. Pharmacist informed and apologized to the patient. Also, pharmacist provided information that there was no need for the patient to repeat the dose. Adverse effects have not been reported by the patient yet.
patient is experiencing tingling/numbess in RIGHT arm immediately after injection.    Patient denies SOB, difficulty breathing or swallowing, swelling of mouth, tongue or lips. RN observed unequal grip strength L>R.   Patient reports intermittent lightheadedness, dizziness.    RN notified  MD to evaluate patient.    Around 17.25 patient reports rash has appeared on mid arm.  MD notified.    CMA, RN or MD remained with patient during entirety of episode.  RN recommended patient have a family member or friend transport her home; patient voiced agreement and contacted mother.    Patient's mother came to clinic to transport home.  Patient transported to lobby at 17.50 in wheelchair.
This happens every time I get the Covid vaccine. About 4-5 hours after injection I get the chills and shake slightly.   I then go to sleep.  When I wake the next morning my blood pressure is very low.  So low that it is hard to walk because of dizziness.  So much so that I will  crawl to go to the restroom or to get water.  I have very little appetite and just want to sleep.  This will last an entire day.  On the second morning after the injection my blood pressure will not be as low as the first day afterwards, and good enough to carefully walk around the house (and sometimes forced to sit on the floor or hold onto an object to regain control) to get water, a bit of food, and go to the bathroom, and this slowly improves throughout the day, and by the second night i'm much better, but not 100% yet and have an appetite back.  On the third day after the injection, I'm back to normal.  I never feel nauseous nor have a fever.
Information has been received through the manufacturer Pregnancy Registry from a certified genetics counselor concerning a 35 year old female, with no pertinent medical history, who on 24-FEB-2007 terminated a pregnancy. On 28-FEB-2007 the patient was vaccinated with Varivax. In March 2007, one month post vaccination, the patient was positive for pregnancy. On 16-APR-2007 an in-office pregnancy test was taken and the pregnancy was confirmed. An ultrasound is due to be completed to determine if the termination of the initial pregnancy had "failed", or whether this is a second pregnancy. Unspecified medical attention was sought. There was no product quality complaint. Follow up information has been received through the manufacturer Pregnancy Registry from a healthcare worker who reported that the patient, who had no previous pertinent medical history, developed an ectopic pregnancy, and was given methotrexate to induce an abortion. The patient was not recovered at the time of reporting. There was no product quality complaint. Additional information has been requested.
I initially had symptoms one would expect from the second dose, including chills, body aches, headache, insomnia, thirst, physical restlessness and fatigue.  They resolved within around 48 hours, after a really good night's sleep.  The issue I'm reporting is one that may or may not be connected.  I had been treated for inflammation in my hands and feet, for about two years, which had mostly resolved by December 2020.  My massage therapist told me I was ready to stop treatment and I wasn't taking anti-inflammatory medication.  I had not seen a rheumatologist because my blood work showed no evidence of an autoimmune condition.  Instead, I had been treating my symptoms through physical therapy, massage therapy and OTC anti-inflammatories, with two rounds of steroids.  Following my second Moderna dose, I noticed pain, stiffness and swelling returning to my hands, as well as discomfort in my feet, knees, shoulders and other areas.  The tendons (e.g. flexor tendons in fingers) and tissue are inflamed, not the joints.  At first, I assumed the return of symptoms was merely a coincidence, but over time I began to wonder if the return of inflammation was a response to my immune system being triggered by the second shot.  (I am very grateful for having the vaccine and would get it again, despite my daily physical discomfort.)  I finally discussed my symptoms with my primary care provide, at the beginning of May 2021.  He prescribed a six-day pack of steroids and daily Meloxicam 15-mg.  I have been getting orthopedic massages to treat my hands/arms, for which I have a prescription.  My symptoms were at their peak, during the month of May, once the steroids wore off and my inflammation returned.  There has been some improvement over the past week, specifically less pain and more flexibility in my fingers.  At times, in late May, the symptoms were severe enough that I couldn't braid my hair or pick up a plastic bag of garbage.  I also had difficulty grabbing doorknobs, holding a kitchen knife and completing other tasks that involved grasping or making a fist, because I had difficulty bending some of my fingers and some would briefly lock in a "trigger" position.  Although my symptoms have shown some improvement, over the past week, the condition is far from resolved.
Immediately after the vaccine, my lips felt tingly and my face started to feel numb. I kept pressing on my cheeks because they felt strange. Stayed a bit for some observation. I left but still had symptoms but later that day my throat started not feeling great. I went to Urgent Care, lips got tingly; my face felt numb and my throat felt uncomfortable. Those symptoms lasted two days. I went to Urgent Care. January 18th, they did a test for an Strep infection negative result. But my throat looked raw and red, they said they weren't sure if I was sick or was having an adverse event from the vaccine. I believe I was given antibiotic. The tingling was gone the next day, the 19th, and the sore throat lasted for about about a month. I did have to go back to Urgent care on the 31st of January when 1st antibiotics didn't work.
Beginning at about 12am I had light soreness in my arm after my 3rd dose. When I woke up on the 26th at 10am I had fever, chills, sore everywhere, nausea, and headache. I called doctor Wednesday morning and they told me to take OTC  Acetaminophen, I slept for over 16hrs. I took my temperature 100.9 late Wednesday evening. I was not allowed to return to school or work until my temperature was under 100. 12 hours into Thursday the symptoms subsided and I was fine and soreness in arm subsided.
pt recvd vax; devel a rash below inject site on each arm w/in 12 hrs of immun; also rash on chest; no fever; fussy; both arms sore
Redness, swelling, hot to the touch. Tx. Cefazolin powder for injection 500 mg.
Patient reported having soreness in right arm, following administration of vaccine. The patient states his right arm is weak and he has trouble lifting objects that are heavy. The patient is a drummer and states he has trouble approx 1 hour into his performing. The patient states he can feel a small "knot" at the site of the injection.
later that night patient began to have extreme back pain, legs hurt even to touch (lasted for days),  knees rubbery ...patient had pain for 11 days...patient had dizziness and his balance was off...patient had difficulty breathing ...patient stayed in the er all day underwent a battery of tests "all day"  ...in the end didnt have answers ....still having  problems breathing and coughing ...patient was zapped of all energy and had difficulty even dressing self
Given flu shot 10/28 afternoon. Rash on chin that evening. Hives went away without treatment. Returned following AM on hand and eye. BENADRYL given and hives improved.
Patient received second dose of COVID vaccine. Upon administration of vaccine, patient's arm began to bleed and swell. Firm pressure was applied and a cool compress was provided. Patient was instructed to take an anti inflammatory for her swelling. After 15 minutes patient was fine and ok to leave
Severe shoulder pain vax site spreading to other shoulder. Numbness right side of face. Large swelling left shoulder below vaccination site.
area around inject became red & severe itching; area in center of redness hard about size of quarter;
When the Pharmacist stuck the needle in my are he was unable to depress the plunger and it hurt really bad, he pulled out the suringe and blood squirted out of my left arm. He then stuck it in again in a different spot and injected vaccine into my arm. The next day I woke up and was in pain my sholder was killing me and I could not move it without sharp stabbing pain.  Ive been to my Dr. and specialist and have not found any relief.
Patient got most of the vaccine but some did bead up and roll down his arm; Roll down his arm; Some did bead up and roll down his arm; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete dose administered in a male patient who received Herpes zoster (Shingrix) (batch number YC5Y7, expiry date 25-OCT-2024) for prophylaxis.   On 08-JUN-2023, the patient received the 1st dose of Shingrix. On 08-JUN-2023, an unknown time after receiving Shingrix, the patient experienced incomplete dose administered (Verbatim: Patient got most of the vaccine but some did bead up and roll down his arm), exposure via skin contact (Verbatim: Roll down his arm) and inadvertent exposure to vaccine (Verbatim: Some did bead up and roll down his arm). The outcome of the incomplete dose administered, exposure via skin contact and inadvertent exposure to vaccine were unknown.   Additional Information: GSK Receipt Date: 09-JUN-2023 The reporter reported that he or she was giving a patient the first dose of Shingrix on day before reporting and had a syringe failure. The patient got most of the vaccine, but some did bead up and roll down patient's arm, which led to incomplete dose administered, inadvertent exposure to vaccine and exposure via skin contact. The vaccine administration facility was the same as primary reporter. The health care provider declined to provide patient's initials and date of birth. The reporter consent to follow up via postal.
PHYSICIAN STATES PATIENT RECEIVED JOHNSON AND JOHNSON VACCINE ON 07/23/2021. BECAME ILL 08/06/2021, RESULTING IN COVID PNEUMONIA AND PATIENT'S EXPIRATION ON 09/05/2021
09/10/2010. Employee received flu vaccine yesterday. C/O today of headache, nausea initially. One hour later c/o vomiting. Presently leaving work to go home.
27 y/o M presented to the ER on 26 Nov 2008 with a 1-week history of significant polyuria and polydipsia.  Also about 1 month history of tiring easily and about 10-15 pound weight loss over 1-2 month period.  Admitted for hydration, electrolyte replacement, and Insulin titration, as well as diabetes self management training.  After 3 days, he was discharged on Glucophage and insulin supplementation with Aspart.  Over the course of the next 12 months, SM was followed up by a civilian Endocrinologist.  During that time, a number of combinations of oral medications were tried, but in Nov 2009, he was placed on an insulin regimen of Lantus with Novolog supplementation before meals and prn for hyperglycemia.  SM denies a history of elevated glucose or blood pressure levels or history of hypertension prior to T1DM diagnosis.  He was very active and had a normal BMI (23.92) prior to diagnosis.  SM has no family history of diabetes.  Does not recall any infections in 3-6 months prior to T1DM diagnosis.
1 hr after injection developed chills. Several hrs later temperature 101 degrees F, nausea, body myalgia, diarrhea.
doses given after temperature excursion; doses given after temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses given after temperature excursion) and PRODUCT STORAGE ERROR (doses given after temperature excursion) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039F21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 28-Nov-2021, the patient experienced PRODUCT STORAGE ERROR (doses given after temperature excursion). On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses given after temperature excursion). On 28-Nov-2021, PRODUCT STORAGE ERROR (doses given after temperature excursion) had resolved. At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses given after temperature excursion) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication information was not provided by the reporter.  Treatment information was not provided by the reporter.
Gradual increase in soreness from injection site, spreading to top of trapezius muscle, mid upper arm, and side of chest.   7/10 pain when doing physical activity.  No treatment administered.
arm sore; slight fever the next day; bouts of fatigue over the next two weeks; This is a spontaneous report from a non-contactable consumer (patient herself). An unspecified aged female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunization. The patient medical history includes Multiple sclerosis, Allergy, food intolerance. The concomitant medications were not reported. It was stated that events took place after use of product. On an unspecified date, the patient experienced arm sore, slight fever the next day and bouts of fatigue over the next two weeks. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
7 days post vaccine enlarging erythematous, warm, tender circular skin lesion(6cm x 5 cm); reactive lymphadenopathy L axilla
2 days later I started experiencing dizziness, light headed, vertigo type symptoms.  Some days lingered more than other days.  Never in the morning until today.  All other days it pops up sometime during the day.  This morning I awoke with this dizziness.  Does not affect me when exercising.  I don't lose my balance or haven't lost my balance.
I received my first dose of Pfizer COVID-19 vaccine on 04/23/2021.    Nine days post-vaccination on 05/02/2021 I developed a cold sore on the left side of my lower lip.    Fourteen days post-vaccination on 05/07/2021 I developed a small patch of painful blisters on my right hand, inner area of the knuckle on my ring finger.  On 05/09/2021 I went to the walk-in clinic and was diagnosed with shingles and given a prescription for generic Valtrex.  I am scheduled to receive my COVID-19 booster on 05/14/2021 and at this point I still intend to get it.
Hive-like rash and redness on chest, swelling of the face,  papule rash on chin, mid-cheek and forehead , and mild shortness of breath
headaches; upset stomach; nausea; body aches; Administration date: dose 1: 16Dec2020, Dose 2: 18Jan2021; Administration date: dose 1: 16Dec2020, Dose 2: 18Jan2021; This is a spontaneous report from a contactable consumer. A 48-year-old female patient (non-pregnant) received the second single dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 18Jan2021 at 14:45, in left arm, at single dose, for Covid-19 immunization. Co-suspect drug included acetaminophen (unknown manufacturer) as preventive medication. The patient received the first dose of BNT162B2 vaccine on 16Jan2021 at 17:15, in left arm with preventive acetaminophen and she felt no effects. The patient had not been tested for COVID19 nor before neither since the vaccination. Concomitant medication taken within 2 weeks of vaccination included high pressure medication. On 19Jan2021 at 08:15 the patient experienced headaches, upset stomach, nausea and body aches. She forgot to take that morning her high pressure medication, she took it, but symptoms continued. She expressed that symptoms were mild but noticeable. No treatment was received. The action taken with acetaminophen was unknown. The events resolved on an unspecified date in Jan2021.  Information on the lot/batch number has been requested.
Pt experienced a low grade fever (100.9) and very painful joints after receiving the 2nd dose of the shingrix vaccine.  He started feeling this about 12 hours after the vaccine was given. He received vaccine on 11/20.  He started to feel a lot better today 11/23.
Developed fever of 103 within 24 hours and rash on posterior left upper thigh. Still with fever up to 103  days post vaccines.
COVID-19 Treatment; COVID-19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 44-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 14Mar2021 as dose 1,single (Batch/Lot number: unknown), in left arm, on 04Apr2021 as dose 2,single (Batch/Lot number: unknown), in left arm and on 12Nov2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 43 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "high blood pressure" (unspecified if ongoing); "asthma" (unspecified if ongoing); "polycistic ovaries" (unspecified if ongoing); "anxiety" (unspecified if ongoing). Concomitant medication(s) included: ACETAMINOPHEN; BUSPIRONE; ENALAPRIL; HYDROCHLOROTHIAZIDE; MONTELUKAST; NATURE'S BOUNTY OPTIMAL SOLUTIONS HAIR, SKIN & NAILS; PANTOPRAZOLE; VITAMIN C [ASCORBIC ACID]; VITAMIN D3; VITAFUSION WOMEN'S; ZYRTEC [CETIRIZINE HYDROCHLORIDE]. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19 Treatment". The patient underwent the following laboratory tests and procedures: Blood pressure measurement: high; SARS-CoV-2 test: Unknown results. Therapeutic measures were taken as a result of vaccination failure, covid-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Insomnia, not sleeping well; Lethargy; Soreness; Feels groggy; This case was reported by a consumer via call center representative and described the occurrence of insomnia in a 66-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 1st April 2022, the patient received the 1st dose of Shingrix (intramuscular). On 1st April 2022, less than a day after receiving Shingrix, the patient experienced insomnia, lethargy and pain. In April 2022, the patient experienced groggy. On 2nd April 2022, the outcome of the pain was recovered/resolved. On an unknown date, the outcome of the insomnia, lethargy and groggy were not recovered/not resolved.   It was unknown if the reporter considered the insomnia, lethargy, pain and groggy to be related to Shingrix.     Additional Information: GSK Receipt Date: 04-APR-2022 Reporter's comment: The case was self-reported by the patient. The patient received first dose of Shingrix and experienced insomnia, lethargy and soreness. Till the time of reporting, the patient still felt groggy and was not sleeping well. The soreness resolved the next day. The reporter gave consent to contact HCP (health care professional) but could only provide name. Reporter did not have the lot or expiration date of the vaccine. The reporter consented to follow up.
Cellulitis bilateral deltoids. - KEFLEX 500 mg TIDx10d. - BENADRYL 2 tsp TID prn x 1 w. - Cool compress.